Valuation: Incyte Corporation

Market Cap 25.26B 22.22B 20.95B 19.11B 35.74B 2,425B 36.02B 251B 97.42B 1,234B 94.86B 92.8B 4,016B P/E 2026 *
55.6x
P/E 2027 * 17.2x
Enterprise Value 21.03B 18.5B 17.44B 15.91B 29.76B 2,019B 29.99B 209B 81.11B 1,028B 78.98B 77.26B 3,344B EV / Sales 2026 *
3.54x
EV / Sales 2027 * 3.08x
Free-Float
98.14%
Yield 2026 *
-
Yield 2027 * -
1 day-0.04%
1 week-2.48%
Current month+1.01%
1 month-2.75%
3 months+14.75%
6 months+37.34%
Current year+26.01%
1 week 123.03
Extreme 123.03
128.72
1 month 119.97
Extreme 119.97
130.8
Current year 89.25
Extreme 89.25
132.6
1 year 81.09
Extreme 81.09
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
9/15/26 A Exercice

Chairperson

69,654 0.0344%
8/25/26 A Tax

EVP, Human Resources

-504 0.0002%
8/19/26 A Sell

Chairperson

-10,801 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
-0.10%-2.48%+47.88%+111.85% 25.26B
-0.47%+1.06%+38.27%-4.41% 80.07B
+4.71%+20.86%+638.21%+94.61% 72.7B
-0.07%+2.70%-10.41%-28.96% 60.45B
-1.80%-3.05%-14.24%+26.38% 46.24B
+0.14%+1.58%+3.62%+165.87% 45.97B
+0.24%+4.01%+65.49%-10.66% 33.62B
-3.48%+6.06%+6.80%+166.49% 22.95B
-0.82%-2.20%+57.40%+97.29% 15.44B
+1.93%-0.27%+32.54%+147.90% 12.85B
Average +0.08%+4.32%+86.56%+76.63% 41.55B
Weighted average by Cap. +0.46%+6.38%+128.06%+56.09%

Financials

2026 *2027 *
Net sales 5.94B 5.23B 4.93B 4.5B 8.41B 570B 8.47B 59.12B 22.91B 290B 22.31B 21.83B 945B 6.27B 5.51B 5.19B 4.74B 8.86B 601B 8.93B 62.34B 24.16B 306B 23.52B 23.01B 996B
Net income 466M 410M 386M 352M 659M 44.72B 664M 4.64B 1.8B 22.76B 1.75B 1.71B 74.06B 1.5B 1.32B 1.24B 1.13B 2.12B 144B 2.13B 14.88B 5.77B 73.08B 5.62B 5.49B 238B
Net Debt -4.23B -3.72B -3.51B -3.2B -5.98B -406B -6.03B -42.09B -16.31B -207B -15.88B -15.54B -672B -5.99B -5.27B -4.97B -4.53B -8.48B -575B -8.54B -59.61B -23.1B -293B -22.49B -22.01B -952B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
24/09/26 $124.61 -0.03% 502,910
23/09/26 $124.64 -1.80% 1,534,432
22/09/26 $126.93 +1.83% 1,647,176
21/09/26 $124.65 -0.53% 1,270,531
18/09/26 $125.31 -1.81% 3,700,438
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
124.64USD
Average target price
127.74USD
Spread / Average Target
+2.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock